Guggenheim downgraded NextGen Healthcare to Neutral from Buy after NextGen agreed to be acquired by Thoma Bravo for $23.95 per share.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NXGN:
- NextGen Healthcare downgraded to Equal Weight from Overweight at Stephens
- NextGen (NASDAQ:NXGN) Jumps on Acquisition Deal with Thoma Bravo
- NextGen Healthcare to be acquired by Thoma Bravo for $23.95 per share in cash
- Thoma Bravo in advanced talks to buy NextGen Healthcare, Bloomberg says
- NextGen Healthcare (NASDAQ:NXGN) Nears Acquisition by Thoma Bravo
